US Stock MarketDetailed Quotes

RAPT RAPT Therapeutics

Watchlist

2.720
-0.070-2.51%

Close Jul 3 13:00 ET

2.700
-0.020-0.74%

Post 15:28 ET

94.94MMarket Cap-883P/E (TTM)

RAPT Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-45.60%-27.08M

-37.13%-97.05M

-21.47%-27.75M

-27.61%-21.88M

-89.59%-28.81M

-19.41%-18.6M

-15.97%-70.77M

-10.48%-22.85M

-36.98%-17.15M

-9.19%-15.2M

Net income from continuing operations

-4.27%-30.52M

-39.31%-116.8M

-34.53%-30.88M

-47.73%-31.37M

-31.78%-25.28M

-43.01%-29.27M

-21.15%-83.84M

-28.01%-22.95M

-13.85%-21.24M

-19.08%-19.18M

Operating gains losses

----

-204.47%-655K

--0

----

143.02%627K

-282.61%-88K

111.56%366K

685.71%550K

Depreciation and amortization

5.02%314K

16.14%1.22M

28.17%323K

25.00%325K

-1.82%269K

14.56%299K

5.12%1.05M

9.09%252K

13.54%260K

7.03%274K

Other non cash items

0.00%584K

32.67%2.34M

22.18%584K

36.21%583K

37.09%584K

36.45%584K

--1.76M

--478K

--428K

--426K

Change In working capital

-126.30%-1.88M

511.91%5.5M

65.98%-990K

1,745.71%5.81M

-6,423.23%-6.46M

424.87%7.13M

68.94%-1.34M

46.86%-2.91M

-89.60%315K

91.96%-99K

-Change in prepaid assets

-189.18%-437K

161.29%871K

89.55%-223K

-17.33%124K

633.33%480K

-24.85%490K

19.44%-1.42M

0.47%-2.13M

-84.08%150K

80.04%-90K

-Change in payables and accrued expense

-110.00%-728K

97.71%7.34M

73.00%-71K

847.70%6.38M

-543.51%-6.25M

284.82%7.28M

297.64%3.71M

89.95%-263K

-78.15%673K

1,192.66%1.41M

-Change in other current liabilities

-12.15%-711K

-29.09%-2.71M

-35.41%-696K

-35.43%-688K

-29.51%-689K

-16.76%-634K

---2.1M

---514K

---508K

---532K

-Change in other working capital

----

55.96%-1.53M

--0

0.45%-886K

Cash from discontinued investing activities

Operating cash flow

-45.60%-27.08M

-37.13%-97.05M

-21.47%-27.75M

-27.61%-21.88M

-89.59%-28.81M

-19.41%-18.6M

-15.97%-70.77M

-10.48%-22.85M

-36.98%-17.15M

-9.19%-15.2M

Investing cash flow

Cash flow from continuing investing activities

-37.23%15.89M

328.91%104.13M

150.01%20.64M

246.31%25.75M

410.16%32.44M

6.17%25.31M

44.08%-45.49M

-159.69%-41.27M

-24.16%-17.6M

83.58%-10.46M

Net PPE purchase and sale

86.17%-105K

-33.14%-1.13M

-36.73%-67K

18.52%-66K

58.83%-233K

-409.40%-759K

-11.92%-845K

87.56%-49K

-15.71%-81K

-784.38%-566K

Net investment purchase and sale

-38.65%15.99M

335.77%105.26M

150.23%20.71M

247.36%25.82M

430.27%32.67M

8.68%26.07M

44.60%-44.65M

-165.98%-41.22M

-24.21%-17.52M

84.45%-9.89M

Cash from discontinued investing activities

Investing cash flow

-37.23%15.89M

328.91%104.13M

150.01%20.64M

246.31%25.75M

410.16%32.44M

6.17%25.31M

44.08%-45.49M

-159.69%-41.27M

-24.16%-17.6M

83.58%-10.46M

Financing cash flow

Cash flow from continuing financing activities

7,689.66%9.04M

-98.90%1.45M

-99.39%458K

-97.98%106K

-98.48%767K

-12.12%116K

-7.28%131.18M

12,438.94%75.36M

1,012.50%5.25M

-63.74%50.44M

Net common stock issuance

--8.97M

--0

-6.94%129.79M

39,806.91%75.03M

--4.98M

----

Proceeds from stock option exercised by employees

-42.24%67K

3.95%1.45M

37.13%458K

-61.03%106K

17.28%767K

-12.12%116K

-31.16%1.39M

-19.13%334K

-42.37%272K

-35.63%654K

Cash from discontinued financing activities

Financing cash flow

7,689.66%9.04M

-98.90%1.45M

-99.39%458K

-97.98%106K

-98.48%767K

-12.12%116K

-7.28%131.18M

12,438.94%75.36M

1,012.50%5.25M

-63.74%50.44M

Net cash flow

Beginning cash position

21.91%47.48M

62.09%38.95M

95.39%54.14M

-12.31%50.16M

41.18%45.77M

62.09%38.95M

-3.58%24.03M

-53.82%27.71M

-33.65%57.2M

31.14%32.42M

Current changes in cash

-131.68%-2.16M

-42.81%8.53M

-159.23%-6.66M

113.46%3.97M

-82.26%4.4M

-18.70%6.82M

1,774.41%14.92M

131.25%11.24M

-12.49%-29.5M

-59.70%24.79M

End cash Position

-0.99%45.32M

21.91%47.48M

95.39%54.14M

-12.31%50.16M

41.18%45.77M

62.09%38.95M

-53.82%27.71M

-33.65%57.2M

Free cash flow

-40.43%-27.19M

-37.08%-98.17M

-21.50%-27.82M

-27.39%-21.95M

-84.26%-29.04M

-23.11%-19.36M

-15.92%-71.62M

-8.65%-22.9M

-36.87%-17.23M

-12.74%-15.76M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

Unqualified Opinion with Explanatory Notes

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-45.60%-27.08M	-37.13%-97.05M	-21.47%-27.75M	-27.61%-21.88M	-89.59%-28.81M	-19.41%-18.6M	-15.97%-70.77M	-10.48%-22.85M	-36.98%-17.15M	-9.19%-15.2M
Net income from continuing operations	-4.27%-30.52M	-39.31%-116.8M	-34.53%-30.88M	-47.73%-31.37M	-31.78%-25.28M	-43.01%-29.27M	-21.15%-83.84M	-28.01%-22.95M	-13.85%-21.24M	-19.08%-19.18M
Operating gains losses	----	-204.47%-655K	--0	--0	----	----	143.02%627K	-282.61%-88K	111.56%366K	685.71%550K
Depreciation and amortization	5.02%314K	16.14%1.22M	28.17%323K	25.00%325K	-1.82%269K	14.56%299K	5.12%1.05M	9.09%252K	13.54%260K	7.03%274K
Other non cash items	0.00%584K	32.67%2.34M	22.18%584K	36.21%583K	37.09%584K	36.45%584K	--1.76M	--478K	--428K	--426K
Change In working capital	-126.30%-1.88M	511.91%5.5M	65.98%-990K	1,745.71%5.81M	-6,423.23%-6.46M	424.87%7.13M	68.94%-1.34M	46.86%-2.91M	-89.60%315K	91.96%-99K
-Change in prepaid assets	-189.18%-437K	161.29%871K	89.55%-223K	-17.33%124K	633.33%480K	-24.85%490K	19.44%-1.42M	0.47%-2.13M	-84.08%150K	80.04%-90K
-Change in payables and accrued expense	-110.00%-728K	97.71%7.34M	73.00%-71K	847.70%6.38M	-543.51%-6.25M	284.82%7.28M	297.64%3.71M	89.95%-263K	-78.15%673K	1,192.66%1.41M
-Change in other current liabilities	-12.15%-711K	-29.09%-2.71M	-35.41%-696K	-35.43%-688K	-29.51%-689K	-16.76%-634K	---2.1M	---514K	---508K	---532K
-Change in other working capital	----	----	----	----	----	----	55.96%-1.53M	--0	--0	0.45%-886K
Cash from discontinued investing activities
Operating cash flow	-45.60%-27.08M	-37.13%-97.05M	-21.47%-27.75M	-27.61%-21.88M	-89.59%-28.81M	-19.41%-18.6M	-15.97%-70.77M	-10.48%-22.85M	-36.98%-17.15M	-9.19%-15.2M
Investing cash flow
Cash flow from continuing investing activities	-37.23%15.89M	328.91%104.13M	150.01%20.64M	246.31%25.75M	410.16%32.44M	6.17%25.31M	44.08%-45.49M	-159.69%-41.27M	-24.16%-17.6M	83.58%-10.46M
Net PPE purchase and sale	86.17%-105K	-33.14%-1.13M	-36.73%-67K	18.52%-66K	58.83%-233K	-409.40%-759K	-11.92%-845K	87.56%-49K	-15.71%-81K	-784.38%-566K
Net investment purchase and sale	-38.65%15.99M	335.77%105.26M	150.23%20.71M	247.36%25.82M	430.27%32.67M	8.68%26.07M	44.60%-44.65M	-165.98%-41.22M	-24.21%-17.52M	84.45%-9.89M
Cash from discontinued investing activities
Investing cash flow	-37.23%15.89M	328.91%104.13M	150.01%20.64M	246.31%25.75M	410.16%32.44M	6.17%25.31M	44.08%-45.49M	-159.69%-41.27M	-24.16%-17.6M	83.58%-10.46M
Financing cash flow
Cash flow from continuing financing activities	7,689.66%9.04M	-98.90%1.45M	-99.39%458K	-97.98%106K	-98.48%767K	-12.12%116K	-7.28%131.18M	12,438.94%75.36M	1,012.50%5.25M	-63.74%50.44M
Net common stock issuance	--8.97M	--0	--0	--0	--0	--0	-6.94%129.79M	39,806.91%75.03M	--4.98M	----
Proceeds from stock option exercised by employees	-42.24%67K	3.95%1.45M	37.13%458K	-61.03%106K	17.28%767K	-12.12%116K	-31.16%1.39M	-19.13%334K	-42.37%272K	-35.63%654K
Cash from discontinued financing activities
Financing cash flow	7,689.66%9.04M	-98.90%1.45M	-99.39%458K	-97.98%106K	-98.48%767K	-12.12%116K	-7.28%131.18M	12,438.94%75.36M	1,012.50%5.25M	-63.74%50.44M
Net cash flow
Beginning cash position	21.91%47.48M	62.09%38.95M	95.39%54.14M	-12.31%50.16M	41.18%45.77M	62.09%38.95M	-3.58%24.03M	-53.82%27.71M	-33.65%57.2M	31.14%32.42M
Current changes in cash	-131.68%-2.16M	-42.81%8.53M	-159.23%-6.66M	113.46%3.97M	-82.26%4.4M	-18.70%6.82M	1,774.41%14.92M	131.25%11.24M	-12.49%-29.5M	-59.70%24.79M
End cash Position	-0.99%45.32M	21.91%47.48M	21.91%47.48M	95.39%54.14M	-12.31%50.16M	41.18%45.77M	62.09%38.95M	62.09%38.95M	-53.82%27.71M	-33.65%57.2M
Free cash flow	-40.43%-27.19M	-37.08%-98.17M	-21.50%-27.82M	-27.39%-21.95M	-84.26%-29.04M	-23.11%-19.36M	-15.92%-71.62M	-8.65%-22.9M	-36.87%-17.23M	-12.74%-15.76M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall